LGND - Company ID 0000886163
LIGAND PHARMACEUTICALS INC trades as LGND and has a market capitalization of $6.35 B, making it the #1243 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $268.09M, up 60.4% from the prior year and net income of $124.45M. This page tracks LIGAND PHARMACEUTICALS INC through 2,218 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years LIGAND PHARMACEUTICALS INC's revenue grew from $108.97M to $268.09M, a compound annual growth rate of 10.5%. Net profit margin expanded from -1.5% to 46.4% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Proxy materials | DEFA14A | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Insider trade | 4 | 2026-05-14 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-05-07 |
| Insider trade | 4 | 2026-05-04 |
Ligand Pharmaceuticals Incorporated - Ligand to Participate in June Investor Conferences
Ligand Pharmaceuticals Incorporated - Ligand Reports First Quarter 2026 Financial Results
Ligand Pharmaceuticals Incorporated - Ligand to Participate in May Investor Conferences
Ligand Pharmaceuticals Incorporated - Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Webcast: Live and replay webcasts of the call are available here .
The largest companies sharing LIGAND PHARMACEUTICALS INC's SEC industry classification (pharmaceutical preparations).
LIGAND PHARMACEUTICALS INC (LGND) has a market capitalization of $6.35 B as of 2026-07-09, ranking #1243 among US-listed companies.
LIGAND PHARMACEUTICALS INC reported revenue of $268.09M for fiscal year 2025, an increase of 60.4% year over year.
Yes. LIGAND PHARMACEUTICALS INC reported net income of $124.45M in its latest fiscal year.